The week in review


(L-R): Outgoing PSA CEO Lance Emerson, PSA National President Shane Jackson, AMA President Dr Michael Gannon.
(L-R): Outgoing PSA CEO Lance Emerson, PSA National President Shane Jackson, AMA President Dr Michael Gannon.

As the year draws to a close, we take a look at the last week in pharmacy

We learned that the opinions of pharmacy owners and employees have never been so widely divided, with the launch of the UTS Pharmacy Barometer: and while overall there’s optimism, employee pharmacists remain pessimistic about how much they’re paid. Here are nine key take-aways from the findings.

For all the disagreement there’s been between GPs and pharmacists this year, this week saw some friendship, as PSA leaders met with the AMA‘s Dr Michael Gannon to talk about collaborative care and roles for non-dispensing pharmacists.

We found that when it comes to opioids, Oxycontin and fentanyl use is much higher than the use of heroin, and usage rates are higher in the bush. And talking of opioids, Amcal is rolling out personalised plans to help people currently treating pain with OTC codeine, ahead of the February upschedule.

Direct supply isn’t going away, as Amgen amended its Prolia offer. eRx hit a milestone: two billion clinical records. And we learned NPS MedicineWise is to say goodbye to Lynn Weekes, who has been its CEO for two decades.

This will be the last Week in Review for 2017; look out for our end-of-year wrapup next week. And from all of us at AJP and Post Script, have a safe and happy festive season.

Previous The supergroup factor
Next Increased asthma risk over summer holidays

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

1 Comment

  1. lundybob
    16/12/2017

    Should the LAST week in pharmacy be the PAST week ?? I hope I have not lost my job yet

Leave a reply